Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jesse I. Treu currently holds 1,877,091 shares of Clovis Oncology, Inc. (CLVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jesse I. Treu has been a net buyer of CLVS stock. They have purchased $114.3M and sold $99.4M worth of shares.
Jesse I. Treu's most recent insider trade was on Mar 26, 2019, when they sold 96,298 shares at $10.01 per share.
Jesse I. Treu serves as Executive at Clovis Oncology, Inc. (CLVS). They have executed 312 insider transactions totaling $213.7M over their tenure at the company.
Jesse I. Treu holds the position of Executive at Clovis Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jesse I. Treu has shown a buying trading pattern, with $114.3M in total purchases and $99.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jesse I. Treu was on Mar 19, 2014, when they sold $102.4M worth of CADX shares. This transaction involved 7,313,241 shares at $14.00 per share.
Jesse I. Treu currently owns 1,877,091 shares of Clovis Oncology, Inc. (CLVS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jesse I. Treu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jesse I. Treu has 312 Form 4 filings on record as an insider at Clovis Oncology, Inc..
Set alerts for Jesse I. Treu and 40,000+ other insiders.